Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 348

recruiting
3 968
countries
28
conditions
2 103

10 282 trials match your criteria

Cerebrovascular accident

Not yet recruiting

Effect of baclofen, gabapentin and oxazepam on brain plasticity and motor learning in subacute stroke patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baclofen

Eosinophilic oesophagitis

Not yet recruiting

Dupilumab Maintenance Dose Optimization in Adults with Eosinophilic Esophagitis: A Randomized Controlled Non‑Inferiority Study

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab

Skin ulcer

Not yet recruiting

Safety and Efficacy of EscharEx (concentrate of proteolytic enzymes enriched in bromelain) in Adults with Venous Leg Ulcers

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years

Parkinson's disease

Not yet recruiting

Study of VQ-101 to Slow Progression in Adults with GBA1‑Associated Parkinson’s Disease

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Phase I study of 161Tb-PSMA-1 therapy and gallium‑68 gozetotide imaging in adult patients with metastatic clear cell renal cell carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide

Optic ischaemic neuropathy

Not yet recruiting

Efficacy and Safety of Intranasal Cenegermin in Adults with Non‑Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cenegermin

Analgesic therapy

Not yet recruiting

Efficacy and safety of dexibuprofen (S‑ibuprofen) gel versus placebo for pain relief in patients with acute soft‑tissue contusions, with background paracetamol

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Dexibuprofen
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD0120

Neoplasm

Not yet recruiting

Study of sacituzumab govitecan versus investigator’s choice drug combination in patients with cancer of unknown primary after platinum‑based chemotherapy failure

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate

Fluorescence bronchoscopy to assess durvalumab-680LT distribution in unresectable stage III non‑small cell lung cancer patients after chemoradiation

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab

Evaluating tirzepatide and letrozole for reducing tumor growth in postmenopausal hormone‑receptor‑positive breast cancer patients

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole

Deafness

Not yet recruiting

Safety, Tolerability and Efficacy of Intracochlear SENS-601 in Children with GJB2‑Related Hearing Loss

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.